Evidence map›Paper›PMID 35556179›Full record

ReviewMycorrhiza2022

Arbuscular mycorrhizal fungi and production of secondary metabolites in medicinal plants.

YanYan Zhao, Annalisa Cartabia, Ismahen Lalaymia, Stéphane Declerck

Open access · hybridAbstract readReview
In one paragraph

Review in Mycorrhiza, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
27.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 138 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Analysis of microbial diversity inFrontiers in microbiology · 2026
    Article
  15. Extracts of the Algerian FungusJournal of fungi (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

YanYan ZhaoUniversité catholique de Louvain, Earth and Life Institute, Mycology, Croix du Sud 2, box L7.05.06, 1348, Louvain-la-Neuve, Belgium.
Annalisa CartabiaUniversité catholique de Louvain, Earth and Life Institute, Mycology, Croix du Sud 2, box L7.05.06, 1348, Louvain-la-Neuve, Belgium.
Ismahen LalaymiaUniversité catholique de Louvain, Earth and Life Institute, Mycology, Croix du Sud 2, box L7.05.06, 1348, Louvain-la-Neuve, Belgium.
Stéphane DeclerckUniversité catholique de Louvain, Earth and Life Institute, Mycology, Croix du Sud 2, box L7.05.06, 1348, Louvain-la-Neuve, Belgium. stephan.declerck@uclouvain.be.ORCID http://orcid.org/0000-0002-0459-5975
UCLouvain · BE

Funding

H2020 Marie Skłodowska-Curie Actions 721635
6 · The paper itself

Abstract

Medicinal plants are an important source of therapeutic compounds used in the treatment of many diseases since ancient times. Interestingly, they form associations with numerous microorganisms developing as endophytes or symbionts in different parts of the plants. Within the soil, arbuscular mycorrhizal fungi (AMF) are the most prevalent symbiotic microorganisms forming associations with more than 70% of vascular plants. In the last decade, a number of studies have reported the positive effects of AMF on improving the production and accumulation of important active compounds in medicinal plants.In this work, we reviewed the literature on the effects of AMF on the production of secondary metabolites in medicinal plants. The major findings are as follows: AMF impact the production of secondary metabolites either directly by increasing plant biomass or indirectly by stimulating secondary metabolite biosynthetic pathways. The magnitude of the impact differs depending on the plant genotype, the AMF strain, and the environmental context (e.g., light, time of harvesting). Different methods of cultivation are used for the production of secondary metabolites by medicinal plants (e.g., greenhouse, aeroponics, hydroponics, in vitro and hairy root cultures) which also are compatible with AMF. In conclusion, the inoculation of medicinal plants with AMF is a real avenue for increasing the quantity and quality of secondary metabolites of pharmacological, medical, and cosmetic interest.

Indexed as

MycorrhizaePlants, MedicinalFungiPlant RootsSoilSymbiosisSoilAeroponicsArbuscular mycorrhiza fungiHairy root culturesHydroponicsMedicinal plantsSecondary metabolites

Identifiers

PMID35556179
PMCPMC9184413
OpenAlexW4280557070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.